Adverse Drug Effects
Thalidomide Sparks Hepatitis Onset In Leukemia Patient
Published in Cancer Weekly, April 10th, 2001
Physicians in Toronto, Ontario, reported a case study in which a patient being treated for end-stage plasma cell leukemia developed hepatitis while being treated with thalidomide. The case was reported in the April 2001 edition of the American Journal of Hematology.
Thalidomide is perhaps best known for the severe developmental effects it can produce in the unborn fetus of a woman who takes it while pregnant. However, in recent years scientists have begun to study the efficacy of thalidomide for a variety of uses, including cancer...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-04-10)
More Articles from Cancer Weekly
- Anti-Angiogenesis
Smaller Doses of Chemotherapy More Frequently May Attack Tumor Blood Supply - Head and Neck Cancer
Phase II Trial Finds Docetaxel-Cisplatin Combination Too Toxic - Cancer Gene Therapy
Scientists Investigate How 'Knots' In DNA Affect Genes - Cancer Therapies
Limiting VEGF Reduces Tumor Resistance to Radiotherapy - Chronic Lymphocytic Leukemia
Clonotypic Test Can Find Minimal Residual Disease - Nasopharyngeal Cancer
Intensity-Modulated Radiation Therapy: Lower Radiation Doses, Improved Target Coverage - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
